June 18, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems and clinical services, is pleased to welcome a prominent cardiovascular practice in Michigan as a new customer utilizing Positron’s Attrius PET System and services. Positron will install the Attrius in Q4 2024 in accordance with the facility’s timeline.
Positron is the only company in the industry offering a dedicated PET scanner. The Attrius is a 2D quantitative PET scanner that is designed for nuclear cardiology, providing high-resolution images in tandem with robust blood flow data for analysis optimal for the latest in coronary flow reserve software, assisting the generation of accurate measurements of absolute blood flow and coronary flow reserve.
Positron’s new Attrius customer will take advantage of the Company’s Lease to Own Program which provides a complete package of an Attrius PET System and the full scope Clinical & Technical Services for one monthly price. Positron’s Lease to Own Program has zero upfront capital expenditure providing the most viable operational model for nuclear imaging practices seeking the PET modality.
Adel Abdullah, President of Positron, stated, “We are pleased to be part of such an established practice and their expansion to include cardiac PET imaging with their current cardiac SPECT based practice. The Attrius PET is a tremendous tool for advanced cardiac studies and diagnostics. Our objectives are to provide our physicians and practices with the best in PET imaging, so that they in turn can provide the best care for their patients at the best value for their practice. Our clinical team provides expert training and clinical support necessary to assure that our customers receive the full benefits of the Attrius PET system, including data quantification and CFR applications. Positron’s Attrius dedicated PET system and services provides nuclear imaging practices the perfect solution through the marriage of high technology and cost-effective imaging solutions. Positron’s Lease to Own Program is an attractive solution for customers seeking cardiac PET imaging and will also open the modality to a broader potential user base. We look forward to providing many more customers customized packages that will enable them to add the Attrius dedicated PET and/or NeuSight PET-CT systems and clinical services to their practices.”
For more information: www.positron.com
December 01, 2025 
